Showing 1,522 results

Filters Content type: News, Editors' picks, About HIV Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Access to healthcare

Generic Companies Join the Medicines Patent Pool

Editor's pick
Medicines Patent Pool
12 October 2011
New & experimental hepatitis C treatment

Pharmasset again expands hepatitis C drug study

Editor's pick
Bloomberg BusinessWeek
11 October 2011
New & experimental hepatitis C treatment

Vertex's Hep C Drug Needs A Growth Injection

Editor's pick
The Street
11 October 2011
Pharmaceutical industry

ViiV Healthcare Starts Phase III Clinical Programme of Celsentri® (maraviroc) versus Truvada® (tenofovir + FTC), in combination with a Protease Inhibitor

Editor's pick
Business Wire
11 October 2011
Access to healthcare

Aurobindo uses patent pool for generic AIDS drugs

Editor's pick
Reuters
11 October 2011
New & experimental HIV treatments

Boehringer signs away HIV rights to focus on hep C - InPharm

Editor's pick
InPharm
7 October 2011
Pharmaceutical industry

Gilead Sciences inks licensing deal for HIV drug -

Editor's pick
Bloomberg BusinessWeek
6 October 2011
Access to healthcare

Study on access to essential HIV/AIDS treatments shows political will as most important factor for success

Editor's pick
International Federation of Pharmaceutical Manufacturers and Associations
5 October 2011
Pharmaceutical industry

Bristol-Myers Is Close To Completing A Groundbreaking Hepatitis C Treatment

Editor's pick
Business Insider
3 October 2011
New & experimental hepatitis C treatment

Vertex takes early rounds of hep C bout with Merck

Editor's pick
Reuters
3 October 2011
Pharmaceutical industry

Are HIV Drugmakers Doomed?

Editor's pick
Motley Fool
30 September 2011
Access to healthcare

Bill Daley's Big Pharma History: Drugs, Profits And Trade Deals

Editor's pick
Huffington Post
29 September 2011
Pharmaceutical industry

Beware: Fake HIV drugs on sale

Editor's pick
Daily Nation
29 September 2011
Clinical trials

The Rise of Unregulated Drug Trials in South America

Editor's pick
The Nation
28 September 2011
Pharmaceutical industry

Kenya drug maker takes a shot at global market

Editor's pick
Business Daily
27 September 2011
New & experimental HIV treatments

Ibalizumab Study Casts a Ray of Hope for HIV-Infected People With Extensive Drug Resistance

Editor's pick
The Body
21 September 2011
Access to healthcare

The UN's Battle With NCDs

Editor's pick
Foreign Affairs
20 September 2011
Access to healthcare

Industry gives pledge on affordable drugs

Editor's pick
Financial Times
20 September 2011
New & experimental HIV treatments

Gilead: Second trial of 4-drug AIDS pill meets goal

Editor's pick
Reuters
19 September 2011
The search for a cure

Sangamo’s Blood-Cell Gene Therapy Fights HIV Without Drugs

Editor's pick
Bloomberg Business Week
18 September 2011
Access to healthcare

Aids groups seek help to counter 'ever-green patents'

Editor's pick
The Nation
13 September 2011
New & experimental HIV treatments

Lofty hopes confront Gilead's 4-drug HIV pill

Editor's pick
Reuters
9 September 2011
Neurological & cognitive problems

HIV Neuropathy Pain Patch Reaches for FDA Approval

Editor's pick
AIDSMeds
9 September 2011
Access to healthcare

India: A victory for Novartis could spell death for millions

Editor's pick
The Hindu
7 September 2011